GL1X · GenesisL1 explorer

Research workbench

Vaccine-elicited nhp fp-targeting antibody 13N024-A.01 in complex with HIV fusion peptide (residue 512-519)

Analyse Vaccine-elicited nhp fp-targeting antibody 13N024-A.01 in complex with HIV… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6PDU
Type
protein
Length
443 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Antibody 13N024-A.01, light chain; Antibody 13N024-A.01, heavy chain; HIV-1 fusion…
Pockets
2 · best druggability 0.62

Structure

x-ray diffraction · 3 distinct chains · 8% helix, 50% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LAntibody 13N024-A.01, light chainprotein2196% helix, 51% strand—
HAntibody 13N024-A.01, heavy chainprotein21610% helix, 51% strand—
CHIV-1 fusion peptide residue 512-519protein80% helix, 0% strand—

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15770.620.7467empty
21290.510.8029empty

Interfaces

3 interfaces between chains.

  • L–H · 1783 Ų buried · 14 hydrogen bonds · protein-protein
  • H–C · 352 Ų buried · 6 hydrogen bonds · protein-protein
  • L–C · 347 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide (disulfide).

Compared structures

  • 6PDU · Vaccine-elicited NHP FP-targeting antibody 13N024-a.01 in complex with HIV fusion peptide… · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.